LUCID DIAGNOSTICS INC.(LUCD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LUCD LUCID DIAGNOSTICS INC.

Market Closed 11-06 16:00:00 EST

0.3980

+0.0079

+2.03%

盘后0.3980

+0.00000.00%

19:17 EST

High0.4005	Low0.3845	Vol1.26M
Open0.3865	D1 Closing0.3901	Amplitude4.09%
Mkt Cap80.89M	Tradable Cap60.68M	Total Shares203.24M
T/O498.10K	T/O Rate0.83%	Tradable Shares152.47M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LUCD","market":"US","secType":"STK","nameCN":"LUCID DIAGNOSTICS INC.","latestPrice":0.398,"timestamp":1793998800000,"preClose":0.3901,"halted":0,"volume":1262781,"hourTrading":{"tag":"盘后","latestPrice":0.398,"preClose":0.398,"latestTime":"19:17 EST","volume":2606,"amount":1034.1016,"timestamp":1794010657550,"change":0,"changeRate":0,"amplitude":0.037186},"delay":0,"changeRate":0.020251217636503508,"floatShares":152466941,"shares":203244000,"eps":-0.461613,"marketStatus":"Market Closed","change":0.0079,"latestTime":"11-06 16:00:00 EST","open":0.3865,"high":0.40045,"low":0.3845,"amount":498102.4501128,"amplitude":0.040887,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.461613,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":7,"adr":0,"listingDate":1634184000000,"exchange":"NASDAQ","adjPreClose":0.3901,"preHourTrading":{"tag":"盘前","latestPrice":0.3978,"preClose":0.3901,"latestTime":"09:28 EST","volume":71343,"amount":28615.9983435,"timestamp":1793975322467,"change":0.0077,"changeRate":0.019739,"amplitude":0.173033},"postHourTrading":{"tag":"盘后","latestPrice":0.398,"preClose":0.398,"latestTime":"19:17 EST","volume":2606,"amount":1034.1016,"timestamp":1794010657550,"change":0,"changeRate":0,"amplitude":0.037186},"volumeRatio":0.6147321201324937},"requestUrl":"/m/hq/s/LUCD","defaultTab":"news","newsList":[{"id":"2680521130","title":"Lucid Diagnostics Joins Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2680521130","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680521130?lang=en_us&edition=fundamental","pubTime":"2026-11-04 21:55","pubTimestamp":1793800528,"startTime":"0","endTime":"0","summary":"Lucid Diagnostics Joins Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumLucid Diagnostics will attend Canaccord Genuity MedTech, Diagnostics and Digital Health & Services For","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL2gTTrZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAVM","LUCD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680493721","title":"Lucid Diagnostics Study Shows 95% Cell Collection Success with EsoCheck in 11,991 Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2680493721","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680493721?lang=en_us&edition=fundamental","pubTime":"2026-11-03 21:15","pubTimestamp":1793711754,"startTime":"0","endTime":"0","summary":"Lucid Diagnostics study shows 95% cell collection success with EsoCheck in 11,991 patientsLucid Diagnostics announced published real-world study results for its EsoGuard esophageal precancer test in t","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nNDL1Kb4xP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LUCD","PAVM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679440277","title":"Lucid Diagnostics to Host Third-Quarter Business Update Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2679440277","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679440277?lang=en_us&edition=fundamental","pubTime":"2026-10-29 20:33","pubTimestamp":1793277185,"startTime":"0","endTime":"0","summary":"Lucid Diagnostics to Host Third-Quarter Business Update CallLucid Diagnostics will host a business update conference call and webcast on November 12, 2026, at 8:30 a.m. ET.The agenda includes third-qu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nNDL4NzJ9g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PAVM","LUCD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678180784","title":"Analysts Offer Insights on Healthcare Companies: Sutro Biopharma (STRO), Lucid Diagnostics (LUCD) and MIRA Pharmaceuticals, Inc. (MIRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2678180784","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678180784?lang=en_us&edition=fundamental","pubTime":"2026-10-25 18:40","pubTimestamp":1792924851,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sutro Biopharma (STRO), Lucid Diagnostics (LUCD) and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sutro-biopharma-stro-lucid-diagnostics-lucd-and-mira-pharmaceuticals-inc-mira-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sutro-biopharma-stro-lucid-diagnostics-lucd-and-mira-pharmaceuticals-inc-mira-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","BK4581","BK4588","HCSG","BK4082","BK4551","BK4137","LU0128526141.USD","LABU","STRO","BK4555","LCID","XBI","BK4007","LU0029874061.USD","BK4099","LCIZ","LUCD","MIRA","XLV","BK4596","LCDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677267179","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2677267179","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677267179?lang=en_us&edition=fundamental","pubTime":"2026-10-23 19:10","pubTimestamp":1792753842,"startTime":"0","endTime":"0","summary":"Lucid Diagnostics (LUCD) stock was 34% higher pre-bell Friday after the company said it has begun receiving Medicare reimbursement payments for its EsoGuard esophageal DNA test and has simultaneously ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","SAIQ","RNG","BK4023","BK4082","LUCD","BK4179","BK4528","STAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677599462","title":"Lucid Diagnostics Raises Series C Preferred Capital Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2677599462","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677599462?lang=en_us&edition=fundamental","pubTime":"2026-10-23 04:59","pubTimestamp":1792702769,"startTime":"0","endTime":"0","summary":"Lucid Diagnostics ( ($LUCD) ) just unveiled an update. On October 21, 2026, Lucid Diagnostics raised approximately $15.0 million by issuing 15,000 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-raises-series-c-preferred-capital-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-raises-series-c-preferred-capital-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LUCD","BK4099","LCIZ","BK4082","BK4596","BK4555","BK4551","LCDL","LCID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677699941","title":"Lucid Diagnostics Closes $15 Million Preferred Stock Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2677699941","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677699941?lang=en_us&edition=fundamental","pubTime":"2026-10-23 04:25","pubTimestamp":1792700748,"startTime":"0","endTime":"0","summary":"Lucid Diagnostics Closes $15 Million Preferred Stock Private PlacementLucid Diagnostics closed a $15 million private placement of Series C Convertible Preferred Stock on October 21, 2026.Shares sold f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nNDL8VZv2N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAVM","BK4082","LUCD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677999959","title":"Lucid Diagnostics Begins Receiving Medicare Reimbursement for Esoguard® and Closes $15 Million Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2677999959","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677999959?lang=en_us&edition=fundamental","pubTime":"2026-10-23 04:21","pubTimestamp":1792700482,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nFWN4682S3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","LUCD","PAVM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676551476","title":"Lucid Diagnostics Faces Nasdaq Minimum Bid Price Noncompliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2676551476","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676551476?lang=en_us&edition=fundamental","pubTime":"2026-10-17 05:00","pubTimestamp":1792184458,"startTime":"0","endTime":"0","summary":"The latest update is out from Lucid Diagnostics ( ($LUCD) ). On October 12, 2026, Lucid Diagnostics disclosed that it received a notice from Nasdaq...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-faces-nasdaq-minimum-bid-price-noncompliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-faces-nasdaq-minimum-bid-price-noncompliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4551","LCID","BK4082","LCDL","LCLG","LUCD","BK4596","BK4555","LCIZ","BK4099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676511019","title":"Lucid Diagnostics Receives NASDAQ Notice for Failing Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2676511019","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676511019?lang=en_us&edition=fundamental","pubTime":"2026-10-17 04:32","pubTimestamp":1792182738,"startTime":"0","endTime":"0","summary":"Lucid Diagnostics Receives Nasdaq Notice for Failing Minimum Bid Price RequirementLucid Diagnostics received a Nasdaq noncompliance notice on October 12, 2026, for breaching Listing Rule 5550(a)(2)'s ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261016:nNDL2H50jt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LUCD","PAVM","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672766118","title":"Needham sees no reason for Lucid Diagnostics selloff today","url":"https://stock-news.laohu8.com/highlight/detail?id=2672766118","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672766118?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:20","pubTimestamp":1790871639,"startTime":"0","endTime":"0","summary":"Needham says the firm spoke to Lucid Diagnostics (LUCD) to understand possible reasons for today’s selloff. Management is not aware of news or othe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/needham-sees-no-reason-for-lucid-diagnostics-selloff-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/needham-sees-no-reason-for-lucid-diagnostics-selloff-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4099","LCID","BK4551","LCDL","BK4555","LCIZ","BK4596","LUCD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147769","title":"Lucid Diagnostics advances Medicare reimbursement and coding infrastructure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147769","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147769?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:29","pubTimestamp":1790083753,"startTime":"0","endTime":"0","summary":"Lucid Diagnostics ( ($LUCD) ) has provided an update. On September 22, 2026, Lucid Diagnostics announced key advances in payment, billing and codin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-advances-medicare-reimbursement-and-coding-infrastructure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-advances-medicare-reimbursement-and-coding-infrastructure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVI","CURE","MHIG","MEDI","FHLC","LNGR","LU0708994859.HKD","IEHS","LCDL","LU0433182093.SGD","HCA","BK4585","BK4588","LUCD","RXD","LU0310800379.SGD","BK4099","AGNG","LCIZ","LU0868494617.USD","PINK","SG9999014039.USD","PTH","TRUH","IHI","LU1084165304.USD","RSPH","SG9999014013.SGD","TMED","BMED","IHF","LU1267930490.SGD","MHIP","BK4551","LU1150488135.SGD","IYH","LCID","XLVX","HTEC","JHMH","PSCH","DVXV","LU0203347892.USD","FXH","BK4082","XHE","LU0310799852.SGD","IE00B3S45H60.SGD","REZ","IE00B775SV38.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659114436","title":"Lucid Diagnostics (LUCD) Receives a Buy from Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2659114436","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659114436?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:56","pubTimestamp":1786712174,"startTime":"0","endTime":"0","summary":"In a report released today, Anthony Vendetti from Maxim Group maintained a Buy rating on Lucid Diagnostics, with a price target of $2.00. According...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lucid-diagnostics-lucd-receives-a-buy-from-maxim-group-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lucid-diagnostics-lucd-receives-a-buy-from-maxim-group-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4551","LCID","LCDL","LUCD","BK4099","LCIZ","BK4596","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659714620","title":"Press Release: PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659714620","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659714620?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:00","pubTimestamp":1786708800,"startTime":"0","endTime":"0","summary":"-- Increased patient onboarding at OSU-The James as commercial phase. of strategic engagement accelerated and clinical rollout continued. -- Continued development of the implantable physiological monitor. toward an early 2027 FDA 510 submission, with design freeze. nearing completion and manufacturing test runs performing well in. preliminary verification and validation ahead of final clinical. -- Lucid Diagnostics announced second quarter 2026 financial results and key. -- Recognized $1.5 million in EsoGuard Esophageal DNA Test revenue. -- Secured first laboratory benefit manager coverage po","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4082","R","LUCD","PAVM","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659157305","title":"Lucid Diagnostics Reports Q2 Growth Ahead of Medicare Decision","url":"https://stock-news.laohu8.com/highlight/detail?id=2659157305","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659157305?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:48","pubTimestamp":1786625333,"startTime":"0","endTime":"0","summary":"Lucid Diagnostics ( ($LUCD) ) just unveiled an update. On August 13, 2026, Lucid Diagnostics reported that second-quarter 2026 revenue rose to $1.5...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-reports-q2-growth-ahead-of-medicare-decision?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-reports-q2-growth-ahead-of-medicare-decision?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4555","LCDL","BK4099","LNGR","LCIZ","BK4596","LUCD","LCID","BK4551","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659376154","title":"PAVmed Subsidiary Lucid Diagnostics Posts 2Q Revenue of USD 1.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659376154","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659376154?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:09","pubTimestamp":1786622978,"startTime":"0","endTime":"0","summary":"PAVmed subsidiary Lucid Diagnostics posts 2Q revenue of USD 1.5 millionPAVmed subsidiary Lucid Diagnostics posted 2Q26 revenue of USD 1.5 million from its EsoGuard esophageal DNA test.Test volume reac","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL6k2GHD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LUCD","BK4082","PAVM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659200151","title":"Press Release: Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659200151","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659200151?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:00","pubTimestamp":1786622400,"startTime":"0","endTime":"0","summary":"-- Processed 2,770 EsoGuard Esophageal DNA Tests in 2Q26.-- Secured a commercial coverage policy for EsoGuard from Concert, a. healthcare technology company recently acquired by Lyric that establishes. laboratory testing policies its client health plans can adopt. The policy. recognizes EsoGuard as medically necessary for patients meeting. established screening criteria and has already been adopted by multiple. -- Developed a health economic cost-effectiveness model evaluating EsoGuard. screening to support commercial payor engagement and coverage decisions,with preliminary results demonstrating improved clinical outcomes and. $1.5 million. Operating expenses were approximately $14.3 million, which","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAVM","BK4232","BK4555","BK4022","LCDL","BK4596","BK4551","BK4082","LCIZ","LUCD","BK4099","LCID","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659868521","title":"Lucid Diagnostics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659868521","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659868521?lang=en_us&edition=fundamental","pubTime":"2026-08-13 06:22","pubTimestamp":1786573365,"startTime":"0","endTime":"0","summary":"Lucid Diagnostics Inc reports results for the quarter ended June 30 - Earnings SummaryLucid Diagnostics IncLUCD.OQreported a quarterly adjusted loss of 8 cents per share for the quarter ended June 30,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N4492B3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAVM","LUCD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659531188","title":"Lucid Diagnostics Inc: Qtrly REV $1.5 Mln, EPS $-0.08 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659531188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659531188?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:37","pubTimestamp":1786567052,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN44917X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LUCD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188849","title":"Lucid Diagnostics Q2 FY26 Revenue Rises 25% to USD 1.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188849","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188849?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:32","pubTimestamp":1786566748,"startTime":"0","endTime":"0","summary":"Lucid Diagnostics Q2 FY26 revenue rises 25% to USD 1.5 millionLucid Diagnostics posted Q2 revenue of USD 1.5 million, up 25% from a year earlier.Sales and marketing expense climbed to USD 5.8 million ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLmsHMy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PAVM","LUCD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.luciddx.com","stockEarnings":[{"period":"1week","weight":-0.0168},{"period":"1month","weight":-0.3617},{"period":"3month","weight":-0.5885},{"period":"6month","weight":-0.6136},{"period":"1year","weight":-0.628},{"period":"ytd","weight":-0.6349}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.035074},{"month":2,"riseRate":0.8,"avgChangeRate":0.165426},{"month":3,"riseRate":0.4,"avgChangeRate":-0.121674},{"month":4,"riseRate":0.4,"avgChangeRate":-0.088036},{"month":5,"riseRate":0.4,"avgChangeRate":0.027971},{"month":6,"riseRate":0.4,"avgChangeRate":-0.052518},{"month":7,"riseRate":0.4,"avgChangeRate":-0.01165},{"month":8,"riseRate":0.8,"avgChangeRate":0.050913},{"month":9,"riseRate":0.2,"avgChangeRate":-0.189588},{"month":10,"riseRate":0.8,"avgChangeRate":0.056692},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.036673},{"month":12,"riseRate":0.2,"avgChangeRate":-0.154424}],"exchange":"NASDAQ","name":"LUCID DIAGNOSTICS INC.","nameEN":"LUCID DIAGNOSTICS INC."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LUCID DIAGNOSTICS INC.(LUCD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LUCID DIAGNOSTICS INC.(LUCD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LUCID DIAGNOSTICS INC.,LUCD,LUCID DIAGNOSTICS INC.股票,LUCID DIAGNOSTICS INC.股票老虎,LUCID DIAGNOSTICS INC.股票老虎国际,LUCID DIAGNOSTICS INC.行情,LUCID DIAGNOSTICS INC.股票行情,LUCID DIAGNOSTICS INC.股价,LUCID DIAGNOSTICS INC.股市,LUCID DIAGNOSTICS INC.股票价格,LUCID DIAGNOSTICS INC.股票交易,LUCID DIAGNOSTICS INC.股票购买,LUCID DIAGNOSTICS INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LUCID DIAGNOSTICS INC.(LUCD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LUCID DIAGNOSTICS INC.(LUCD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction